L
Lupin Ltd
Pharmaceuticals
LARGECAP
Pharmaceuticals
Live Performance vs
This is a tool to communicate factual return information and should not be seen as an advertisement or promotion
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 50.18 | 50.69 |
| PB Ratio | 6.68 | 6.47 |
| Dividend Yield | 0.38% | 0.52% |
Understand what these metrics mean.
Peer Stocks
For peer comparison & financials,
About the company
L
Lupin Ltd
Lupin Limited is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world.
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions